These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37376970)

  • 1. Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.
    Ando N; Mizushima D; Takano M; Mitobe M; Kobayashi K; Kubota H; Miyake H; Suzuki J; Sadamasu K; Aoki T; Watanabe K; Uemura H; Yanagawa Y; Gatanaga H; Oka S
    J Antimicrob Chemother; 2023 Aug; 78(8):2070-2079. PubMed ID: 37376970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
    Murray GL; Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Fairley CK; Jensen JS; Williamson DA; Tan LY; Mokany E; Durukan D; Bradshaw CS
    J Infect Dis; 2020 Mar; 221(6):1017-1024. PubMed ID: 32031634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of circulating dual-class resistant
    Ando N; Mizushima D; Takano M; Mitobe M; Miyake H; Yokoyama K; Sadamasu K; Aoki T; Watanabe K; Uemura H; Yanagawa Y; Gatanaga H; Oka S
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab091. PubMed ID: 34223146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
    Murray GL; Plummer EL; Bodiyabadu K; Vodstrcil LA; Huaman JL; Danielewski JA; Chua TP; Machalek DA; Garland S; Doyle M; Sweeney EL; Whiley DM; Bradshaw CS
    Clin Infect Dis; 2023 Jun; 76(12):2187-2195. PubMed ID: 36722416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
    Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
    J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of fluoroquinolone-resistance using MIC determination and homology modelling of ParC of contemporary Mycoplasma genitalium strains.
    Hamasuna R; Hanzawa H; Moritomo A; Matsumoto M; Aono H; Tomisaki I; Akasaka T; Fujimoto N; Jensen JS
    J Infect Chemother; 2022 Mar; 28(3):377-383. PubMed ID: 34836778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan.
    Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M
    J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
    Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
    BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of
    Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of
    Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Bradshaw CS; Birnie J; Ebeyan S; Lundgren M; Murray G
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33612146
    [No Abstract]   [Full Text] [Related]  

  • 13. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T; Kikuchi M; Yasuda M; Ito S
    J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of
    Wang L; Li Z; Wan C; Tian X; Liu H; Li Y
    Int J STD AIDS; 2023 Jul; 34(8):518-524. PubMed ID: 36929876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide and fluoroquinolone resistance associated mutations in Mycoplasma genitalium in men who have sex with men attending STI clinic: A pilot study from India.
    Biswal D; Gupta S; Sethi S; Singh S; Khanna N; Dhawan B
    Indian J Dermatol Venereol Leprol; 2024; 90(5):632-635. PubMed ID: 38899414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife].
    Mateo León C; García Martínez de Artola D; Pino-Calm B
    Rev Esp Quimioter; 2023 Aug; 36(4):416-420. PubMed ID: 37149902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
    Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
    Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Sandri A; Carelli M; Visentin A; Savoldi A; De Grandi G; Mirandola M; Lleo MM; Signoretto C; Cordioli M
    Front Cell Infect Microbiol; 2023; 13():1155451. PubMed ID: 37065200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
    Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
    Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.